Sucampo execs to get hefty bonuses tied to proposed sale

The company, which announced its intention to sell to U.K. pharmaceutical Mallinckrodt for $1.2 billion, including debt, is generously rewarding its top executives for executing on the deal.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news